Skip to main content

Table 6 Dose of interferon received and actual dose intensity.

From: Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI – Mel.A.) [ISRCTN75125874]

 

DD/DI arm (N = 86)

HDI arm (N = 80)

 

Mean (SD)

Median (Range)

Mean (SD)

Median (Range)

Target dose (MU/m2)

1600

 

1840

 

MU/m2 received

974.6 (455.6)

1034.4 (40 -1620.2)

1052.2 (509.2)

1155.9 (20-1888.9)

Target DI* MU/m2/week

50

 

35.4

 

Actual DI MU/m2/week

37.1 (10.8)

36.4 (5–52.1)

34.1 (14.4)

30.7 (5–91.8)

% of target DI

0.74 (0.2)

0.73 (0.1–1.0)

0.96 (0.4)

0.87 (0.1–2.6)

  1. *DI: Dose Intensity